Molecular Partners Ag (MOLN) Tax Provisions (2020 - 2026)
Molecular Partners Ag (MOLN) posted quarterly Tax Provisions of $7.15 for Q1 2026, up 221.48% year-on-year from $2.22 in Q1 2025, and down 99.71% on a QoQ basis from $2495.3 in Q4 2025.
Molecular Partners Ag (MOLN) Tax Provisions (2020 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Tax Provisions for 7 consecutive years, with $7.15 the latest figure, recorded in Q1 2026.
- Quarterly Tax Provisions rose 221.48% year-over-year to $7.15 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2516.2 (up 10.1% YoY) and the FY2025 annual result came in at $2502.3, up 9.61% from the prior year.
- Tax Provisions declined to $7.15 in Q1 2026 per MOLN's latest filing, from $2495.3 in the prior quarter.
- Over the last five years, Tax Provisions for MOLN reached as high as $2495.3 in Q4 2025 and fell as low as -$12.85 in Q4 2023.
- A 5-year average of $320.54 and a median of $6.45 in 2023 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2023 — Tax Provisions sank 113.47% — and 2024, when it soared 17813.7%.
- Year by year, Tax Provisions stood at -$6.02 in 2022, then plunged by 113.47% to -$12.85 in 2023, then surged by 17813.7% to $2276.5 in 2024, then increased by 9.61% to $2495.3 in 2025, then plunged by 99.71% to $7.15 in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $7.15, $2495.3, and $7.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Molecular Partners Ag | 147.97 Mn | 147.97 Mn | - | 7.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.15 |
| Dec 31, 2025 | 2,495.33 |
| Sep 30, 2025 | 7.00 |
| Jun 30, 2025 | 6.76 |
| Mar 31, 2025 | 2.22 |
| Dec 31, 2024 | 2,276.54 |
| Sep 30, 2024 | 6.58 |
| Mar 31, 2024 | 6.53 |
| Dec 31, 2023 | -12.85 |
| Sep 30, 2023 | 6.45 |
| Mar 31, 2023 | 6.16 |
| Dec 31, 2022 | -6.02 |
| Sep 30, 2022 | 6.01 |
| Jun 30, 2022 | -6.02 |
| Mar 31, 2022 | 6.28 |
| Dec 31, 2021 | 2,163.47 |
| Sep 30, 2021 | 5.55 |
| Dec 31, 2020 | -12,179.88 |
| Sep 30, 2020 | 26.07 |